Paweł K. Mazur

EGF Receptor Is Required for KRAS-Induced Pancreatic Tumorigenesis

Christine Ardito-Abraham, Barbara M. Grüner, Kenneth K. Takeuchi et al. · Cancer Cell · 2012 · 515 citations

Pancreatic Cancer, Egf Receptor, Medicine +3

SMYD3 links lysine methylation of MAP3K2 to Ras-driven cancer

Paweł K. Mazur, Nicolas Reynoird, Purvesh Khatri et al. · Nature · 2014 · 405 citations · Full text

Lysine Methylation, Medicine, Cancer Genomics +5

Combined inhibition of BET family proteins and histone deacetylases as a potential epigenetics-based therapy for pancreatic ductal adenocarcinoma

Paweł K. Mazur, Alexander Herner, Stephano S. Mello et al. · Nature Medicine · 2015 · 401 citations · Full text

Histone Modifications, Chromatin, Tumor Biology +12

A Drug Repositioning Approach Identifies Tricyclic Antidepressants as Inhibitors of Small Cell Lung Cancer and Other Neuroendocrine Tumors

Nadine S. Jahchan, Joel T. Dudley, Paweł K. Mazur et al. · Cancer Discovery · 2013 · 362 citations · Full text

Notch2 is required for progression of pancreatic intraepithelial neoplasia and development of pancreatic ductal adenocarcinoma

Paweł K. Mazur, Henrik Einwächter, Marcel Lee et al. · Proceedings of the National Academy of Sciences · 2010 · 227 citations · Full text